Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-24 @ 6:41 PM
NCT ID:
NCT02103257
Eligibility Criteria:
Inclusion Criteria:
* Pathologic confirmation of lung adenocarcinoma with measurable disease, defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded on CT)
* Patients must have previously untreated locally advanced or metastatic NSCLC
* EGFR activating mutation (exon 19 deletion, L858R) is required
* Eastern Cooperative Oncology Group performance status (ECOG PS) score of 0 or 1
Exclusion Criteria:
* Prior chemotherapy or treatment with gefitinib, erlotinib, or other drugs that target EGFR
* Patients with wild-type EGFR
* Any other investigational agents are not permitted
* Any evidence of interstitial lung disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02103257
Study Brief:
Protocol Section:
NCT02103257